Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension

European Heart Journal

Volumn 15, Issue 7, 1994, Pages 940-946

  Lenz, T ^b   Schulte, K L ^a   Wagner, B ^a,d   Lilienthal, J ^c   Gotzen, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c DATAMAP GmbH   (Germany)

^d DATAMAP GmbH ^*  (Germany)

Author keywords

Combination therapy; Essential hypertension; Hydrochlorothiazide; Quinapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; QUINAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0028337409     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a060614     Document Type: Article

References (25)

1. Reid JL. Present aspects and future developments with ACE-inhibition. Cardiology 1989; 76 (Suppl 2): 1-10.
2. Waeber B, Nussberger J, Brunner HR. Angiotensin-converting-enzyme inhibitors in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, 1990: 2209-36.
3. Lenz T, Distler A, Haller H et al. Humoral and blood pressure effects of the ACE-inhibitor ramipril in essential hypertension. Arzneimittelforsch 1986; 36: 1693-6.
4. Kaplan HR, Taylor DG, Olson SC, Andrews LK. Quinapril - a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology 1989; 40: 335-50.
5. Frank GJ, Knapp LE, Olson SC et al. Overview of quinapril, a new ACE inhibitor. J Cardiovasc Pharmacol 1990; 15 (Suppl 2): S14-S23.
6. Taylor SH. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension. Angiology 1989; 40: 382-8.
7. Goldstein RJ. The treatment of moderate to severe hypertension with ACE inhibitors. J Cardiovasc Pharmacol 1990; 15 (Suppl 2): S29-S35.
8. Chobanian A. The role of angiotensin converting enzyme inhibitors in the therapy of cardiovascular disease: an overview. Angiology 1989; 40: 331-4.
9. Lenz T, August P. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure. Wien Klin Wochenschr 1990; 102: 315-9.
10. Zanchetti A. The clinical role of angiotensin converting enzyme inhibitors in antihypertensive therapy in the 1990s. J Hypertens 1989; 7 (Suppl 5): S37-S40.
11. Weinberger MH. Clinical use of ACE-inhibitors: combined therapy in hypertension. In: MacGregor GA, Sever PS, eds. Current Advances in ACE-Inhibition. New York: Churchill Livingstone 1989: 117-22.
12. Brunner HR, Gavras H, Waeber B. Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade. Clin Exp Hypertens 1980; A2: 639-57.
13. Weinberger MH. Angiotensin-converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol 1989; 13 (Suppl 3): S1-S4.
14. Leonetti G, Mazzola C, Pasotti C et al. Antihypertensive efficacy and influence on physical activity of three different treatments in elderly hypertensive patients. J Hypertens 1989; 7 (Suppl 6): S304-S305.
15. Maclean D. Quinapril: a double-blind, placebo-controlled trial in essential hypertension. Angiology 1989; 40: 370-81.
16. Frishman WH, Greenberg S. Angiotensin-converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. Am J Hypertens 1991; 4: 827-31.
17. Schnaper HW. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension. Angiology 1989; 40: 389-95.
18. Ruoff G. ACE inhibitors and diuretics - the benefits of combined therapy for hypertension. Postgrad Medicine 1989; 85: 127-39.
19. Mehta J, Lopez ML, Thorman AD. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. Am J Cardiol 1988; 61: 803-6.
20. Dahlöf B, Hansson L, Acosta JH et al. Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. Am J Hypertens 1988; 1: 38-41.
21. Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation 1970; 41: 709-17.
22. Schnaper HW. The management of hypertension in older patients. J Cardiovasc Pharmacol 1990; 15 (Suppl 2): S56-S61.
23. Jenkins AC, Knill JR, Dreslinski GR. Captopril in the treatment of the elderly hypertensive patient. Arch Intern Med 1985; 145: 2029-31.
24. Fries ED. Age and antihypertensive drugs (hydrochlorothiazide, bendrofiumethiazide, nadolol and captopril). Am J Cardiol 1988; 61: 117-21.
25. Brunner HR, Waeber B, Nussberger J. Treatment of hypertension with ACE inhibitors as first step: pharmacologic and clinical considerations. J Cardiovasc Pharmacol 1987; 10 (Suppl 7): S36-S42.